Validation of modified fibrosis-4 index for predicting hepatocellular carcinoma in patients with compensated alcoholic liver cirrhosis

Recently, modified fibrosis-4 index (mFIB-4) and the easy liver fibrosis test (eLIFT) were developed for predicting liver fibrosis in chronic liver disease patients. We evaluated whether the 2 tests can predict hepatocellular carcinoma (HCC) risk in alcoholic liver cirrhosis (ALC) patients. A retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji Hyun, Lee, Minjong, Park, Seung Woo, Kang, Myungho, Kim, Minjeong, Lee, Sang Hoon, Kim, Tae Suk, Park, Jin Myung, Choi, Dae Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283079/
https://www.ncbi.nlm.nih.gov/pubmed/30508959
http://dx.doi.org/10.1097/MD.0000000000013438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283079/
https://www.ncbi.nlm.nih.gov/pubmed/30508959
http://dx.doi.org/10.1097/MD.0000000000013438

Ejemplares similares